Fingerprint
Dive into the research topics of 'Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial
Neurofibromatosis Clinical Trials Consortium
- Division of Hematology & Oncology
- Neurofibromatosis (NF) Center
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- Center of Regenerative Medicine
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences
- Siteman Cancer Center
- DBBS - Neurosciences
- Section of General Pediatric Neurology
- DBBS - Developmental, Regenerative and Stem Cell Biology
- DBBS - Molecular Genetics and Genomics
- DBBS - Cancer Biology
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations